郭峰, 杜傲男, 拾景磊, 沈文彬, 刘亚洲, 孙苏平. 食管癌伴糖尿病患者调强放疗后放射性肺炎发生的临床研究[J]. 中国辐射卫生, 2018, 27(6): 628-630.
GUO Feng, DU Aonan, SHI Jinglei, SHEN Wenbin, LIU Yazhou, SUN Suping. Clinical study of radiation pneumonitis in patients with esophageal cancer and diabetes after intensity-modulated radiotherapy. , 2018, 27(6): 628-630.
[1] Lutz SZ,Staiger H,Fritsche A,et al.Antihyperglycaemictherapiesand cancer risk[J].Diab Vasc Dis Res,2014,11(6):371-389.
[2] 朱莉菲,张秋玲.糖尿病与恶性肿瘤的相关性研究进展[J].医学综述,2017,23(13).
[3] 萧丽军,缪珩,祝群,等.2型糖尿病并发恶性肿瘤的风险因素分析[J].中国糖尿病杂志,2013,21(2):169-171.
[4] 韩蕾,卢冰,付和谊,等. Ⅲb~Ⅳ期非小细胞肺癌同期放化疗临床因素与放射性肺炎相关性研究[J].中华放射肿瘤学杂志, 2011,20(1):23-26.
[5] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CACancerJClin,2015,65(2):87-108.
[6] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CACancerJClin,2015,65(2):87-108.
[7] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J].CACancerJClin,2016,66(2):115-132.
[8] Wei WQ, Yang J, Zhang SW, et al. Analysis of the esophageal cancer mortality in 2004-2005 and its trends during last 30 years in China[J]. Zhonghua Yu Fang Yi Xue Za Zhi, 2010, 44(5):398-402.
[9] Marks LB,Bentzen SM,Deasy JO, et al.Radiation dose-volume effect in the lung[J].Int JR adiat Oncol Biol Phs,2010,76(3):70-76.
[10] 陈凤,李全福,金高娃,等.重组人粒细胞刺激因子治疗急性放射性黏膜炎的疗效观察[J].中国辐射卫生,2016,25(6):749-752.
[11] 祖国红,李福生,王厚伟.放射防护膏(Rp)对乳腺癌皮肤放疗反应的疗效观察[J].中国辐射卫生, 2014,23(2):187-190.
[12] Plama DA,Senan S,Tsujino K,et al. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer:An Internation Individal Patient Data Meta-analysis[J]. Int JR adiat Oncol Biol Phs,2013,87(4):690-696.
[13] 鲍艳红,黄常新.放射性肺炎的发病机制及其防治研究进展[J].实用医学杂志,2015,31(21):3621-3623.
[14] 陈伟,宫帅,尹静静,等.肺癌放射治疗致放射性肺炎的临床疗效分析[J].中国实用医药,2014,9(27):7-9.
[15] 陈静.肺癌放疗患者放射性肺炎优质护理的应用[J].中西医结合护理:中英文,2015,1(2):40-41.
[16] 陈多才,康兆君,李秀冬.肺癌伴糖尿病患者放射性肺炎发生率的临床观察[J].吉林医学,2012,33(8):1638-1639.
